Previous close | 72.03 |
Open | 72.11 |
Bid | 72.05 x 1100 |
Ask | 72.36 x 1100 |
Day's range | 71.65 - 72.66 |
52-week range | 62.90 - 81.44 |
Volume | |
Avg. volume | 8,885,145 |
Market cap | 154.466B |
Beta (5Y monthly) | 0.43 |
PE ratio (TTM) | 23.66 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 2.28 (3.15%) |
Ex-dividend date | 05 Jan 2023 |
1y target est | N/A |
Qiagen (QGEN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
There is much to love about dividend stocks beyond their passive-income potential. Companies that distribute regular and consistent dividends tend to have rock-solid businesses that can survive in the most challenging environment. Also, opting for dividend reinvestment can substantially boost returns over the long run.
Bristol Myers Squibb (BMY) closed at $72.45 in the latest trading session, marking a -0.74% move from the prior day.